A clinical approach to dysuria in women by Ramphal, SR
Dysuria is defined as pain, burning or discomfort on urination, which is common-
ly accompanied by frequency or urgency. Although many doctors equate dysuria
with urinary tract infections (UTIs) and treat empirically without adequate evalua-
tion, it is a symptom that is associated with many different clinical entities.
Dysuria is more frequent in young women. A comprehensive history and a step-
wise diagnostic approach, accompanied by inexpensive office laboratory testing,
are usually sufficient to determine the cause of dysuria. Table I lists disorders
associated with symptoms of dysuria and their characteristic symptoms, laborato-
ry and physical findings.
DIFFERENTIATION BY HISTORY
Pain occurring at the start of urination may indicate urethral pathology, whereas
pain occurring at the end of micturition (strangury) is usually of bladder origin.
Dysuria with frequency and urgency with internal discomfort located in the ure-
thra and bladder usually suggests cystitis, while dysuria with external discomfort
suggests labial irritation or associated vaginitis. Sexual intercourse is associated
with many causes of dysuria, but women with postcoital cystitis typically develop
symptoms within a few days of intercourse. 
Women are at risk of developing UTIs because of their short urethra, and certain
behavioural factors which include delay in micturition, sexual activity and the use
of diaphragms and spermicides which promote colonisation of the periurethral
area with coliform bacteria. Haematuria is common with UTI, and is unlikely to
occur with other potential causes. About 15 - 20% of women with acute cystitis
have suprapubic pain.1 Postmenopausal women not receiving hormone replace-
ment therapy are prone to vaginitis and urinary tract infection.
Dysuria associated with a vaginal discharge suggests some type of vaginitis.
Dyspareunia with the sensation of external dysuria is highly suggestive of vagini-
tis. Dysuria at the start of micturition with symptoms of pelvic inflammatory dis-
ease (PID) is suggestive of urethritis.2
Associated fever, myalgia and headaches suggest acute pyelonephritis or genital
herpes as a cause of dysuria. The former usually has renal angle tenderness
while the latter has tender vesicles in the vulva and vaginal area. Dysuria with
post-micturition dribble, frequency, urgency and dyspareunia is highly suspicious
of a urethral diverticulum and needs to be investigated. Questions should be
asked about the use of medications and topical hygiene products since dysuria
can be caused by penicillin G, cyclophosphamide, vaginal sprays, vaginal
douches and bubble baths. Bladder irritation from compression by adnexal mass-
es and radiation or chemical exposure also produces dysuria.  
DIFFERENTIATION ON EXAMINATION
The physical examination is usually not remarkable and special focus should be
placed on the genito-urinary system. In patients with cystitis, only 15 - 20% have
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A CLINICAL APPROACH TO
DYSURIA IN WOMEN
Dysuria is a common presenting symptom among women and is not always associated
with a urinary tract infection.
suprapubic tenderness. Pyrexia, renal
angle tenderness, or deep right or left
upper quadrant tenderness to deep
palpation, suggest acute pyelonephri-
tis. Vaginal atrophy, especially in the
elderly, will reflect the hypo-oestro-
genic state. 
A tender, reddish introitus may suggest
vulvodynia and the presence of a ten-
der suburethral swelling with a ure-






Pyuria is the most sensitive laboratory
indicator for UTI. A positive leucocyte
esterase dipstick test is 75 - 95% sen-
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Table I. Differential diagnosis of dysuria in females
Laboratory and other test
Diagnosis Associated symptoms Physical examination results
Acute cystitis Frequency, urgency 15 - 20% suprapubic Usually positive for pyuria
with occasional tenderness and occasionally positive
haematuria for bacteriuria and nitrite
Subclinical Frequency, urgency May have suprapubic Positive for pyuria,
pyelonephritis with infrequent tenderness. No sometimes positive for
haematuria costovertebral angle bacteriuria and nitrite, urine
tenderness culture >105 colony-
forming units/ml
Acute pyelonephritis Nausea, fever, Costovertebral Pyuria with casts of WBC,
emesis, back/flank angle tenderness. urine culture >105 colony-
pain. History of Deep right or left upper forming units/ml urine
preceding cystitis quadrant tenderness
Urethritis Usually No suprapubic pain, Urethral swab: positive for
asymptomatic. unless associated with WBC, Gram stain for Gram-
If symptoms develop PID, rarely visible urethral negative diplococci. Molecular
they are usually discharge techniques for chlamydia
delayed (> 1 week) and gonorrhoea
Vaginitis External irritation, Vaginal discharge, Positive KOH or vaginal
vaginal discharge or inflamed vaginal mucosa saline preparation, elevated
pruritus, dyspareunia (absent in bacterial pH (bacterial vaginosis,
or premenstrual vaginosis), inflamed CX trichomoniasis)
exaggeration of (trichomoniases), vaginal
symptoms atrophy (postmenopausal)
Genital herpes Dysuria, fever, Grouped vesicles Viral culture (optional)
headaches, myalgia, usually on cervix or pubic
vulval pain area, tender inguinal 
lymphadenopathy
Interstitial cystitis Frequency, urgency, Long-standing Urinalysis negative for
haematuria (20%)     symptoms with negative  WBC or bacteria, positive for
with associated cultures, may have glomerulations on
dysuria suprapubic tenderness cystoscopy
Urethral diverticulum Postmicturition Suburethral swelling, Opening at
dribble, dyspareunia occasional pus expressed cystourethroscopy,
and dysuria from urethra contrast in diverticulum at
voiding cystourethrography
Burning vulvar Dysuria is external, Exquisite tenderness by
syndrome burning sensation on cotton swab palpation on
vulva vestibule, reddish spots
at introitus
KOH = potassium hydroxide.
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sitive in detecting pyuria secondary to
infection.3 Bacteruria and urine nitrite
are frequently present but are less sen-
sitive as markers of UTI. Positive nitrite
is over 90% specific for UTI, but the
sensitivity is only 30%.4 The sensitivity
is increased to 60% if the first voided
morning urine sample is tested.
Therefore a dipstick test that is positive
for nitrite suggests UTI. However a
negative test does not rule out the
diagnosis.
Microscopic examination
Urine microscopic examination of a
clean-catch, spun midstream urine sed-
iment is regarded as the gold stan-
dard for evaluating dysuria. Pyuria is
diagnosed by the presence of 3 - 5
white blood cells per high-power field
and haematuria is diagnosed by the
presence of 3 - 5 red blood cells per
high-power field.5
Urine culture    
Non-pregnant women with uncompli-
cated cystitis do not usually require a
urine culture. However, if it is per-
formed, then more than 103 colony-
forming units/ml is significant. Urine
cultures are also deferred if dysuria is
described as external and a probable
urethral or vaginal cause is identified.
Vaginal or urethral
smears/pH
Increased vaginal pH is characteristic
of trichomoniasis, bacterial vaginosis,
and in conditions where Lactobacillus
is replaced with coliform bacteria.
Urethral smears with more than 5
white blood cells per high-power field
are highly suggestive of a urethritis. 
Vaginal/urethral cultures
Although cultures for Chlamydia tra-
chomatis and Neisseria gonorrhoeae
are the gold standard for identification




Acute cystitis  
Acute cystitis is the most common bac-
terial infection in young women.
Approximately 40% of women will
experience at least one episode of cys-
titis in their lifetime, and 20% will
have recurrent cystitis.  
Pathogenesis
The shorter urethra in women predis-
poses them to ascending infection of
bacteria, especially during sexual
intercourse. Naturally occurring
defence mechanisms that tend to be
protective are indicated below. When
these defence mechanism are disrupt-




• Normal urine has a low pH, a high
osmolality, and a urea content that
makes it a natural bactericide.      
• Normal urine flow and voiding
expels bacteria.
• A protective mucous coating of the
uroepithelial cells inhibits adher-
ence of bacteria.
• Vaginal secretions have a low pH
that inhibits growth of coliform bac-
teria.
Conditions that cause an
increased incidence of
urinary tract infection
• Obstruction or alteration in urine
flow secondary to tumours, stones,
cystocele, pregnancy, and post-
incontinence surgery.
• Disruption of the mucin layer fol-
lowing catherterisation with a
Foley’s catheter, or urinary tract
instrumentation.
• Alteration in the normal vaginal
lactobacillus colonisation, especial-
ly with usage of spermicides
(nonoxynol-9), antibiotics, and post-
menopausal women with oestrogen
deficiency.
Table II lists the likely bacterial
pathogens in uncomplicated and com-
plicated UTIs. 
Treatment
Many episodes of bacterial cystitis
resolve without treatment. Antibiotics
hasten the reduction of symptoms and
prevent the spread of infection into the
upper urinary tract.6
Uncomplicated cystitis can be treated
empirically with a single-dose antibiot-
ic or a 3-day course (Table III). The
use of single-dose antibiotic therapy
has recently fallen into disfavour as
there is a high risk of recurrence with-
in 6 weeks of initial treatment.7 This
was attributed to failure to eradicate
Gram-negative bacteria from the rec-
tum which is a source or reservoir for
ascending infections. It is now accept-
ed that a 3-day regimen offers the
optimal combination of convenience,
low cost and efficacy comparable with
that of a 7-day regimen with fewer
side-effects.8
Recurrent infections are usually re-
infections (infections with different
organisms) separated by an asympto-
matic interval of at least 1 month.
Fortunately, most of these are uncom-
plicated and are generally not associ-
ated with underlying anatomical
abnormalities. They are usually caused
by vaginal and rectal colonisation
with uropathogens.
Patients who have more than 3 UTI
recurrences documented by urine cul-
ture within 1 year should be managed
using one of the three preventive
strategies:
• acute self-treatment with a 3-day
course of standard therapy when
symptoms of UTI develop 
• postcoital prophylaxis with trimetho-
prim-sulfamethoxazole if UTI has
been clearly related to intercourse
• continuous daily prophylaxis for a
period of 6 months with nitrofuran-
toin 100 mg per day, or trimetho-
prim 100 mg per day. 
The above regimens have been shown
to decrease the morbidity of recurrent
UTIs without concomitant increase in
antibiotic resistance.9
Complicated UTIs
Complicated UTIs are defined as those
occurring in women with an anatomi-
cally or functionally abnormal urinary
tract, or in women who are immuno-
compromised, which predisposes them
to persistent infections, recurrent infec-
tions or treatment failure.
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Although many doctors
equate dysuria with urinary
tract infections (UTIs) and
treat empirically without
adequate evaluation, it is a
symptom that is associated
with many different clinical
entities. 
Dysuria with frequency and
urgency with internal dis-
comfort located in the ure-
thra and bladder usually
suggests cystitis, while
dysuria with external dis-
comfort suggests labial irri-
tation or associated vagini-
tis.
Aggressive clinical investigation is
important since only 35% are
Escherichia coli related and they are
more likely to harbour resistant organ-
isms.2 Accurate urine culture and sus-
ceptibility tests are necessary to best
target and eradicate the pathogens.
Therapy consists of broad-spectrum
agents such as quinalone derivatives
for at least 10 - 14 days. Follow-up
urine cultures should be performed
after treatment to ensure complete
cure. 
Subclinical pyelonephritis
This condition represents a diagnostic
challenge since these patients have
renal parenchymal involvement, but
they experience only symptoms of cys-
titis. This clinical condition has impor-
tant therapeutic sequelae, since infec-
tions are more difficult to eradicate
and it requires a 2-week course of
antibiotic therapy compared with the
usual 3-day course for cystitis.
Identifiable factors that increase a
patient's risk for subclinical
pyelonephritis are listed below. Most
patients with this condition tend to
have bacterial counts greater than 105
units/ml on quantitative culture, but
the specificity of this culture is not high
enough to be clinically useful.
Accessory tests, such as antibody-coat-
ed bacteria assay, erythrocyte sedi-
mentation rate (ESR) and renal cortical
scintigraphy, have been used to identi-
fy patients with subclinical
pyelonephritis but the specificity of
these tests is too poor to make them
useful. 
Risk factors for subclinical pyelonephri-




• anatomic anomaly of the urinary
tract
• vesicoureteral reflux
• relapse of symptoms within 3 days
of treatment for cystitis 
• history of acute pyelonephritis within
1 year.
Interstitial cystitis
Interstitial cystitis is a clinical syn-
drome of urinary frequency and pelvic
pain in a patient in whom no other
pathology can be established. It is sig-
nificantly more common than was orig-
inally believed, affecting an estimated
450 000 people in the USA, 90% of
whom are women.
The median age of diagnosis is 40
years. The diagnosis is difficult to
make and a study showed that
patients on an average have had their
symptoms for 4.5 years before they
were correctly diagnosed.10 Of signifi-
cance, patients with interstitial cystitis
are more likely to have had UTIs both
as children and adults.
The exact aetiology of interstitial cysti-
tis remains unclear and the proposed
theory is that there is an alteration in
the glycosaminoglycan mucous layer,
possibly in response to a previous bac-
terial urinary tract infection, allowing
solutes in the urine to provide an
inflammatory response.
Characteristic features of interstitial
cystitis are:
• symptoms of suprapubic pain with
frequency, urgency, dysuria, noc-
turia and dyspareunia for at least
9 months
• bladder capacity less than 350 ml
and low first sensation and urge to
void (usually less than 150 ml)
• no recent diagnosis of bacterial
cystitis (within last 3 months) 




• Escherichia coli 80
• Staphylococcus saprophyticus 10
• Proteus  mirabilis 5
• Klebsiella pneumoniae 4
• Enterobacter species 1
• β-haemolytic streptococcus < 1
Complicated infections
• Escherichia coli 35
• Entrerococcus faecalis 16
• Proteus mirabilis 24
• Staphylococcus epidermidis 23
• Klebsiella pneumoniae 7
• Pseudomonas aeruginosa 5
• Staphylococcus aureus 4
• Enterobacter species 3
• Others 5
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• no alternative explanation for the
symptoms, e.g. tuberculous cystitis,
radiation cystitis, chemical cystitis
• characteristic cystoscopic appear-
ance.
Definitive diagnosis is made with the
identification of Hunner’s ulcers
(mucosal ulceration on the bladder
wall) or glomerulations (petechial-like
haemorrhages on the bladder
mucosa). 
Treatment
There is no known curative therapy for
interstitial cystitis. Hence management
is directed towards alleviating symp-
toms and improving function. In gener-
al, treatment begins with dietary
changes and oral medication. A com-
bination of Taven-sp, Aterax and an
antidepressant is usually first-line thera-
py. While these agents have been
shown to improve symptoms relative to
placebos, large double-blind, con-
trolled studies evaluating their efficacy
are lacking. Intravesical therapy
including hydrodistension of the blad-
der during cystoscopic evaluation,
dimethyl sulfoxide (DMSO), intravesi-
cal capsaicin and resinferatoxin is usu-
ally used as second-line approach.11
Surgery should be reserved as last
choice for patients in whom other
forms of management have failed.12
Surgical procedures include supratrig-
onal cystectomy with formation of an
enterovesical anastomosis.  
Management of interstitial
cystitis
• Dietary — avoid acidic, alcoholic
or carbonated beverages, spicy
foods, coffee, tea and chocolates.
• Bladder retraining — increasing
time interval between voids.
• Medical therapy 
• pentosan polysulfate (Elmiron)
— 300 mg/day 
• Taven-SP — 50 - 100 mg bd
• amitryptyline (Tryptanol) — start
at 25 mg nocte, increasing by
25 mg every 2 - 4 weeks up to
100 mg 
• imipramine (Tofranil) — 25 mg
nocte
• hydroxyzine (Aterax) — 25 - 50
mg/day nocte
• nifedipine (Adalat) — 30 mg
(extended release) daily
• cimetidine (Tagamet) — 200 mg
3 times/day
CONCLUSION
Dysuria is a common symptom that
family care practitioners are faced
with on a daily basis. Although many
equate dysuria with UTIs it is a symp-
tom with many causes. A detailed his-
tory and simple examination will iden-
tify most causes so that appropriate
therapy can be instituted.  
References available on request.
Table III. Empirical oral antibiotic therapy for uncomplicated cystitis in women
Drug Dose Active
Single dose 
• Fosfomycin  3 g sachet — stat Citrobacter, Enterobacter, 
• Amoxicillin 3 g Klebsiella, Serrata species
• Ciprofloxacin 500 mg 
3-day cover
• Trimethoprim sulfa-
methoxazole (Bactrim) 2 tabs bd/3 days
• Nitrofurantoin 100 mg 4x/3 days
• Ciprofloxacin 250 mg bd/3 days
Dysuria is defined as pain, burning or discomfort on urination.
It is commonly accompanied by frequency or urgency.
Pain at the start of urination suggests urethral pathology, while pain at the end of urination suggests bladder origin.
Haematuria is common with UTI. and is unlikely to occur with other potential causes.
Pyuria is the most sensitive laboratory indicator for UTI.
A positive nitrite test is suggestive of UTI, but a negative test does not rule out the diagnosis.
Other conditions which present with dysuria are cystitis, acute and subclinical pyelonephritis, urethritis, vaginitis, genital
herpes, interstitial cystitis, urethral diverticulum and burning vulvar syndrome.
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